secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001628280-24-046481
Event type: earnings
Sentiment:  positive
Materiality: 0.82
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q3 revenue $9.4M (+89% YoY), operating income $2.0M; Q4 guidance 40-50% growth
--------------------------------------------------------------------------------

- Revenue record of $9.4M, up 89% vs Q3 2023; beat guidance of 65-75% increase.
- UltraMist systems sold: 124 in Q3 2024 vs 55 in Q3 2023; consumables revenue $5.4M (+75%).
- GAAP operating income $2.0M vs loss of $0.5M in Q3 2023; Adj. EBITDA $2.1M vs ($0.3M).
- Net loss $20.7M (driven by derivative liability fair value change); year-to-date loss $18.6M.
- Guides Q4 2024 revenue $9.7-10.5M (+40-50% YoY); FY2024 revenue >$32M; 1-for-375 reverse split Oct 18.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828024046481/0001628280-24-046481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828024046481/snwv-20241108.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-046481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer